Loading...
Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme
OBJECT: Gliadel (BCNU) wafer and concomitant temozolomide (TMZ) therapy, when used individually as adjuvant therapies, extend survival from that achieved by resection and radiation therapy (XRT) for glioblastoma multiforme (GBM). It remains unstudied whether combining Gliadel and TMZ therapy is safe...
Na minha lista:
Udgivet i: | J Neurosurg |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2009
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4856017/ https://ncbi.nlm.nih.gov/pubmed/19046047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2008.5.17557 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|